ONO-7436 Phase 3 Study

Phase 3

• Conditions: chemotherapy-induced nausea and vomiting

• Registration Number: JPRN-jRCT2080220825
• Lead Sponsor: ONO PHARMACEUTICAL CO.,LTD.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-08-20
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: All
• Target Recruitment: 22

Inclusion Criteria

1.Patients with malignant tumor who are to be treated with an emetogenic chemotherapy regimen that includes either cisplatin, cyclophosphamide, or carboplatin
2.Patients whose performance status is 0 to 2

Exclusion Criteria

1.Patients will receive stem cell rescue therapy in conjunction with course of chemotherapy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Safety [Time Frame: 15 days]<br>2.Proportion of patints with no vomiting and no use of rescue therapy(Complete Response) [Time Frame: 5 days]<br>3.Pharmacokinetics [Time Frame: 4 days]